As the global small nucleic acid drugs market rapidly expands, driven by growing demand for precise treatments targeting genetic disorders, rare diseases, and cancer. The high specificity of small ...
PHILADELPHIA--(BUSINESS WIRE)--Aro Biotherapeutics today announced the appointments of Christopher K. Mirabelli, Ph.D., to its Board of Directors and Masad J. Damha, Ph.D., to its Scientific Advisory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback